UAB has developed a database that promises to be an important tool in fighting COVID-19. PAGER-CoV is packed with nearly 12,000 pieces of genetic information on the SARS-CoV-2 virus, information that researchers and physicians can use to tailor treatments against the disease.
PAGER-CoV is an extension of PAGER, a database of gene sets created by Jake Chen, professor in the UAB Department of Geneticsand associate director of the Informatics Institute in the School of Medicine. Chen created PAGER 10 years ago at Indiana University. As the pandemic spread in early 2020, Chen and his UAB colleagues created a similar system, PAGER-CoV, in response.
The database includes 11,835 PAGs, which stands for pathways, annotated gene lists and gene signatures.
Pathways form a roadmap that describes how genes are turned on and off and how they establish connections with each other.
Annotated gene lists are empirical information that researchers collect from experiments or literature. Gene lists help researchers understand how a certain cell type behaves under different conditions.
A gene signature is a unique pattern of gene expression within a cell from a single gene or group of genes, providing information about the activity of those genes.
SARS-CoV-2 is a new virus, and we didnt know much about its function back in the summer of 2020, Chen said. The goal here is to gather all this information together in a searchable database so that researchers can gain a better understanding of how the viruss genes behave or perform under various biophysical conditions, such as severe COVID-19 or long-haul COVID-19 patients.
Chen said SARS-CoV-2 has 15 genes, with scant information on how they affect human cells.
We need to understand the differences in people who die from COVID-19 versus the person who only has a mild case of the disease, he said. This is a precision medicine approach, employing the database to organize all that weve learned about the virus so that the information can be used in an effective way.
Chen said the downstream effects of coronavirus are not well understood. Better understanding could lead to tailored therapeutics based on gene behavior.
We need to know how the virus proteins are interacting with human cells, and we need to know what we can do about it, he said. There is no shortage of possible therapeutics. There is a shortage of regimens that will pair the right therapeutic with the right person. Precision data-driven medicine is what this work will help COVID-19 physicians understand.
Chens and his colleagues paper on the workings of PAGER-CoV was published in January in Nucleic Acids Research. The team searched the medical literature for all articles dealing with the SARS-CoV-2 virus. They then used super computers that employed data science tools to do comprehensive data processing and integration.
Chen said users can search the database with any human gene or a PAG of interest, drill down to their database entry and navigate to other related PAGs through either shared PAG-to-PAG co-membership relationships or PAG-to-PAG regulatory relationships. To date, there are nearly 20 million PAG-to-PAG relationships in the database.
Our intent is to provide a resource that researchers doing functional genomic studies of COVID-19 will use, Chen said. There is a lot of information here, organized in a way that we hope will spur new insights and lead to meaningful results.
PAGER-CoV will grow as new information is available and added to the database. Chen urges researchers worldwide to use the portal and participate in this community-based knowledge curation effort.
PAGER-CoV is freely available to the public without registration or login requirements (http://discovery.informatics.uab.edu/PAGER-CoV/). The data is available for download based on the agreement of citing this work while using the data from the PAGER-CoV website.
Joint first authors on the paper are Zongliang Yue and Eric Zhang. Additional co-authors are Clark Xu, Sunny Khurana, Nishant Batra, Son Do Hai Dang and James J. Cimino.
PAGER-CoV was developed with support from the UAB Informatics Institute, Academic Enrichment Fund, Center for Clinical and Translational Science, and the National Cancer Institute and National Center for Advancing Translational Sciences of the National Institutes of Health.
This story originally appeared on the University of Alabama at BirminghamsUAB News website.
Read more here:
UAB-developed research tool will help scientists better understand COVID-19 - Alabama NewsCenter
Recommendation and review posted by G. Smith
